MEDTRONIC INC: Court Dismisses Most Claims in “Nowak” Suit

In July 2011, the United States District Court for the District of Massachusetts dismissed the majority of Plaintiff’s claims in the lawsuit captioned United States of America ex rel Tricia Nowak and Enda Dodd v. Medtronic, Inc., according to the…

BAXTER INTERNATIONAL: Gets Favorable Ruling on Heparin Matter

Baxter International Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that with regards to Heparin litigation, in July 2011, the U.S. District Court for the Northern District of Ohio ruled…

BAXTER INTERNATIONAL: Executing Recall of Colleague Pumps

Baxter International Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the company is executing a recall of COLLEAGUE infusion pumps through July 13, 2012 by offering its customers an…

BAXTER INTERNATIONAL: Derivative Suits Ongoing in Illinois

Baxter International Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that several shareholder derivative actions are ongoing against the company.

In May 2010, a shareholder derivative action was brought on behalf…

BAXTER INTERNATIONAL: Trial on Propofol Litigation Set August

Baxter International Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission the next trial in Propofol litigation is scheduled for August 2011.

The company is a defendant, along with others, in numerous…

ST JUDE: Cooperating with US FDA to Resolve CGMP Concerns

St. Jude Medical, Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the Company is working cooperatively with the U.S. Food and Drug Administration (FDA) to resolve current Good Manufacturing…

PFIZER INC: New York Court Approves Settlement on Derivative Suit

The U.S. District Court for the Southern District of New York granted in April 2011 final approval of the settlement agreement with regards to In re Pfizer Inc. Shareholder Derivative Litigation, the company disclosed in its latest quarterly report on…

ST JUDE: Cooperating with US FDA to Resolve Epicor Concerns

St. Jude Medical, Inc. disclosed in its latest quarterly report on

Form 10-Q filed with the U.S. Securities and Exchange Commission

that the Company is working cooperatively with the U.S. Food and

Drug Administration (FDA) to resolve Epicor LP Cardiac Ablation

System and the…

PFIZER INC: Tax Years 2006-2008 Under US IRS Audit

The U.S. Internal Revenue Service (IRS) is currently auditing the 2006, 2007 and 2008 tax years for Pfizer Inc, the company disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission.

The 2009 through…

ST JUDE: Continues to Respond to DOJ Probe on Defibrillator

St. Jude Medical, Inc. disclosed in its latest quarterly report on

Form 10-Q filed with the U.S. Securities and Exchange Commission

that the company continues to respond to a Civil Investigative

Demand initiated by the U.S. Department of Justice (DOJ).

In March 2010, the…

Page 1 of 1012345»...Last »